1. Home
  2. EPIX vs KVAC Comparison

EPIX vs KVAC Comparison

Compare EPIX & KVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • KVAC
  • Stock Information
  • Founded
  • EPIX 2009
  • KVAC 2021
  • Country
  • EPIX Canada
  • KVAC United States
  • Employees
  • EPIX N/A
  • KVAC N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • KVAC
  • Sector
  • EPIX Health Care
  • KVAC
  • Exchange
  • EPIX Nasdaq
  • KVAC Nasdaq
  • Market Cap
  • EPIX 209.4M
  • KVAC 210.5M
  • IPO Year
  • EPIX N/A
  • KVAC 2023
  • Fundamental
  • Price
  • EPIX $1.72
  • KVAC $10.87
  • Analyst Decision
  • EPIX Hold
  • KVAC
  • Analyst Count
  • EPIX 4
  • KVAC 0
  • Target Price
  • EPIX $9.50
  • KVAC N/A
  • AVG Volume (30 Days)
  • EPIX 2.4M
  • KVAC 38.7K
  • Earning Date
  • EPIX 12-10-2024
  • KVAC 01-01-0001
  • Dividend Yield
  • EPIX N/A
  • KVAC N/A
  • EPS Growth
  • EPIX N/A
  • KVAC N/A
  • EPS
  • EPIX N/A
  • KVAC 0.43
  • Revenue
  • EPIX N/A
  • KVAC N/A
  • Revenue This Year
  • EPIX N/A
  • KVAC N/A
  • Revenue Next Year
  • EPIX N/A
  • KVAC N/A
  • P/E Ratio
  • EPIX N/A
  • KVAC $25.20
  • Revenue Growth
  • EPIX N/A
  • KVAC N/A
  • 52 Week Low
  • EPIX $1.40
  • KVAC $10.28
  • 52 Week High
  • EPIX $11.67
  • KVAC $10.91
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 23.15
  • KVAC 68.42
  • Support Level
  • EPIX $1.75
  • KVAC $10.81
  • Resistance Level
  • EPIX $1.89
  • KVAC $10.88
  • Average True Range (ATR)
  • EPIX 0.19
  • KVAC 0.02
  • MACD
  • EPIX -0.10
  • KVAC 0.00
  • Stochastic Oscillator
  • EPIX 7.36
  • KVAC 71.43

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

About KVAC Keen Vision Acquisition Corporation

Keen Vision Acquisition Corp is a blank check company.

Share on Social Networks: